Richard Chin
Managing Director of Ascendant Venture | Board Member and Co-Founder, Bio Usawa and VETmAb | Blogs at richardychin.medium.com and clinicaltrialist.com
San Francisco, California
Invests in
Sectors:
Locations:
Min Investment:
$50,000.00Max Investment:
$1,000,000.00Target Investment:
$100,000.00
Education
Lists including Richard
Work Experience
2022
Managing Director
2022
Family office investing in early stage startups, with a preference for impact-oriented investments
2023
Co-Founder and Chair of the Board
2023
Biotech company bringing affordable biologics to patients in Africa and other LMIC
2021
Founder and Chief Executive Officer
2021
Biopharmaceutical company developing therapies to cure aging
2022
Co-Founder and Chairman of the Board of Directors
2022
Developing life-changing monoclonal antibodies for pets
Board Member
2021
Nonprofit organization supporting Asian American films
2022
Co-Founder and Chairman of the Board of Directors
2022
Genetically improved, healthier nonallergenic pets that bring pets and pet parents closer together
2021 - 2023
Board Member
2021 - 2023
Nonprofit organization dedicated to preserving endangered languages across the planet
2012 - 2021
Founder and Chief Executive Officer
2012 - 2021
Founder and CEO of KindredBio (NASDAQ:KIN), a biotech company developing drugs and biologics for pets (acquired by Elanco)
2010 - 2020
Clinical Associate Professor
2010 - 2020
2011 - 2018
Board Member
2011 - 2018
Biotech company developing therapies for neurological diseases.